Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 12;43(1):e135-e136.
doi: 10.1093/pubmed/fdaa125.

Immunity passports to travel during the COVID-19 pandemic: controversies and public health risks

Chee H Liew  1   2 , Gerard T Flaherty  1   3
Affiliations

Immunity passports to travel during the COVID-19 pandemic: controversies and public health risks

Chee H Liew et al. J Public Health (Oxf). .

Abstract

As countries emerge from pandemic lockdown, many countries are relaxing international travel restrictions. Commercially available serologic tests for anti-SARS-CoV-2 antibodies are being performed. The concept of an 'immunity passport' has gained popularity, whereby evidence of SARS-CoV-2 antibody production would signal immunity to reinfection. For an immunity certificate to be validated for travel purposes, it should meet certain criteria. The introduction of such certificates faces multiple challenges. While there may be a future role for immunity passports in limited circumstances in the event that a protective vaccine becomes freely available, for now at least the risks of such an approach outweigh the perceived benefits.

Keywords: infectious disease; migration; public health.

PubMed Disclaimer

References

    1. Wilson ME, Chen LH. Re-starting travel in the era of COVID-19: preparing anew. J Travel Med 2020. doi: 10.1093/jtm/taaa108. - DOI - PMC - PubMed
    1. Chen LH, Freedman DO, Visser LG. COVID-19 immunity passport to ease travel restrictions? J Travel Med 2020. doi: 10.1093/jtm/taaa085. - DOI - PMC - PubMed
    1. Stringhini S, Wisniak A, Piumatti G et al. . Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet 2020. doi: 10.1016/S0140-6736(20)31304-0. - DOI - PMC - PubMed
    1. Cheng MP, Yansouni CP, Basta NE et al. . Serodiagnostics for severe acute respiratory syndrome-related coronavirus-2: a narrative review. Ann Intern Med 2020. doi: 10.7326/M20-2854. - DOI - PMC - PubMed
    1. Deeks JJ, Dinnes J, Takwoingi Y et al. . Antibody tests for identification of current and past infection with SARS-CoV-2. Cochrane Database Syst Rev 2020;(6):CD013652. - PMC - PubMed

Substances